Patrick McCann to Prostatic Neoplasms
This is a "connection" page, showing publications Patrick McCann has written about Prostatic Neoplasms.
Connection Strength
0.868
-
Case of complete response to immunotherapy in MMR-deficient prostate cancer associated with NK-like and CD4+CD8+ T cells. Cell Rep Med. 2026 Jul 21; 7(7):102889.
Score: 0.191
-
Neoadjuvant Fc-enhanced anti-CTLA-4 targets Tregs to augment androgen deprivation in high-risk prostate cancer: A randomized phase I trial. Cell Rep Med. 2026 Mar 17; 7(3):102638.
Score: 0.186
-
Accelerating Drug Development in Hormone-Na?ve Prostate Cancer through Multimodal Therapy Strategies: The MetaCURE Phase 2 Randomized Clinical Trial. Clin Cancer Res. 2026 Feb 04; 32(3):479-488.
Score: 0.186
-
Androgen Deprivation Therapy Drives a Distinct Immune Phenotype in Localized Prostate Cancer. Clin Cancer Res. 2024 Nov 15; 30(22):5218-5230.
Score: 0.171
-
Quantifying clinical severity of physics errors in high-dose rate prostate brachytherapy using simulations. Brachytherapy. 2021 Sep-Oct; 20(5):1062-1069.
Score: 0.135